The inhibition of the ACE, which converts angiotensin I to the vasoconstrictor agent angiotensin II by lowering blood pressure in cardiovascular disease, is widely reported for the listed peptides (Table 3). The gene discussed is AGT; the disease is cardiovascular disorder.